A Review of Treatment Trials for Dry AMD
Results from studies of oral and injectable agents.
Genentech's Promising Retina Pipeline
Top company researchers discuss major initiatives.
Opthea Expands Program for “Pan-VEGF” Therapy
Company will raise $45 million for wet AMD and DME trials.
The Future of Surgical Retina in the Era of Medical Retina
Commentary from a leader in vitreoretinal surgery.
Shortening the Laser Photocoagulation Learning Curve With a Navigated System
Mastering this can be challenging for residents, but a navigated laser helps expedite training.
Halting and Reversing DR Progression With Anti-VEGF: Clinical and Economic Relevance
The third of a 3-part series.
Widefield Angiography of the Peripheral Retina
A review of modalities for widefield angiography and their application for various pathologies.
Reading Centers vs Clinic-Based Interpretation of OCT Data
Why is my patient ineligible for this study?
Retina Therapy in an International Context
Does location affect how patients receive care?
Update on the Diagnosis and Management of Pediatric Retinal Disease
Part 1 of a 3-part series on non-ROP pediatric retinal conditions.
The Promise of Topicals for Retinal Disease
Researchers pursue combination therapies, repurposing, and new directions to chase “the holy grail.”
Use of OCT to Identify Complete PVD: Clinical Images
A commonly used module of OCT can accurately identify complete PVD.
SUBSPECIALTY NEWS
By Jerry Helzner, contributing editor
Innovation in Retina: Aura Biosciences Seeks to Cure Ocular Melanoma
A disruptive drug and a determined CEO.
NEW PRODUCT APPLICATIONS
Second-Generation OCT Module Goes the Extra Mile